Drag a card by its title · ⚙ to size, swap or remove

Who

Doris Quackenbush

Sales VP

Company insider

Files Form 4 as: Sales VP, Axogen.

Every Form 4 they filed

In numbers

Trades disclosed: 2
Buys: 0
Sells: 1
Bought: $0
Sold: $337K
Companies: 1
Companies where not an officer: 0
First trade: 7 May 2026
Last trade: 7 May 2026
Last filed: 8 May 2026

Companies traded

Where they are an officer

AXGN AxogenOfficer · Medical Devices · last 7 May 20260 buys · 1 sell

Activity over time

1 May – 1 Oct

Buys above the line, sells below, each month.

Every trade

Traded	Company	What	Amount
7 May 2026filed 8 May 2026	AXGN AxogenMedical Devices	SEC FORM 4 Sold	$169K3,878 at $43.51	filing
7 May 2026filed 8 May 2026	AXGN AxogenMedical Devices	SEC FORM 4 Sold	$169K3,878 at $43.51	filing

News

Analyzing AxoGen (NASDAQ:AXGN) & AtriCure (NASDAQ:ATRC)AXGN · tickerreport.com · 18 Oct 2026

0 headlines in the last 90 days name Doris Quackenbush; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.

Sectors

Health Care1

Buys in green, sells in red, by the company’s sector.

Related people

Joseph A. TyndallDirector · Director at Axogen, filing Form 4 there in the last year

Amy McBride WendellDirector · Director at Axogen, filing Form 4 there in the last year

Marc A. BeganEVP & General Counsel · EVP & General Counsel at Axogen, filing Form 4 there in the last year

Kathy Johnson WeilerDirector · Director at Axogen, filing Form 4 there in the last year

Paul ThomasDirector · Director at Axogen, filing Form 4 there in the last year